See today's BioWorld
To read the full story, subscribe or sign in.

Pliant shares bend under IPF bexotegrast phase IIb pause

Feb. 10, 2025
By Randy Osborne
A mysterious turn in the phase IIb story with idiopathic pulmonary fibrosis (IPF) candidate bexotegrast sent shares of Pliant Therapeutics Inc. (NASDAQ:PLRX) down 60.6%, or $4.72, to close Feb. 10 at $3.07.
BioWorld Clinical Respiratory Small molecule U.S.